InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2026-03-30 00:00:00 ET · period of report 2026-03-26 · accession 0001689575-26-000021 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-03-30 2026-03-26 WGS Stueland Katherine CEO, Dir S - Sale+OE $63.17 -46.9K 101.4K -32% -$2.96M
D 2026-03-30 2026-03-26 WGS Stueland Katherine CEO, Dir M - OptEx $0.00 +80.0K 138.4K +137% $0
D 2026-03-30 2026-03-26 WGS Stueland Katherine CEO, Dir M - OptEx $0.00 -80.0K 160.0K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2026-03-26 S D 5,117 $62.33 120,101 D — — (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.93 to $62.91 per share, inclusive.
2 Common Class A Common Stock 2026-03-26 S D 13,229 $61.29 125,218 D — — (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.93 to $61.91 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 7 of this Form 4.
3 Common Class A Common Stock 2026-03-26 M A 80,000 $0.00 138,447 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
4 Common Class A Common Stock 2026-03-26 S D 9,883 $65.21 91,514 D — — (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.61 per share, inclusive. (F8) Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 91,514 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 334,695 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms.
5 Common Class A Common Stock 2026-03-26 S D 13,412 $63.28 106,689 D — — (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.96 to $63.955 per share, inclusive.
6 Common Class A Common Stock 2026-03-26 S D 5,292 $64.60 101,397 D — — (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.99 to $64.96 per share, inclusive.
7 Derivative Restricted Stock Unit 2026-03-26 M D 80,000 $0.00 160,000 D — · — to — 80,000 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F9) 25% of the total award vested or vests annually, with the first tranche vested on March 26, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.